We're moving on!
While we'll no longer be sharing content here, you can still connect with us on LinkedIn, subscribe to our newsletter, or learn more about membership on our website...
https://t.co/Aw0U3htEnM
#Collaboration#HealthcareInnovation#BlockchainTechnology
Don't miss out on the insights & exclusive updates!
Our 1st newsletter of 2025 is around the corner as we look forward to the many exciting collaborations we have in the works!
Subscribe now & be part of our journey!
#digitalhealthcare#blockchainnews
Our Executive Director, Dr. Stefan Schwarzfischer, will be at the "From Clinical Trials to Supply Chains: Digital Tools in #Pharmaceutical Sciences" next week in Bern.
It's free, come discuss how we can put patients at the heart of #ClinicalTrials.
https://t.co/uGaM3SAAxz
Discover how Digital Trust Ecosystems are safeguarding Healthcare 4.0 in our latest PLA Insights podcast episode.
https://t.co/vs5gONjIWV
#digitaltrust#HealthcareInnovation
"I am grateful for the opportunity to have contributed as both a speaker and moderator during this insightful session [AUTOMA+]. It was truly inspiring to exchange ideas on the digital frontier in pharma and healthcare." - Stefan Schwarzfischer, Dr.-Eng., PLA Executive Director
Dr. Stefan Schwarzfischer, PLA’s executive director, will be at the Pharmaceutical Automation & Digitalisation Congress (AUTOMA+) in Switzerland next week!
Join us as we delve into the "Digital Frontier" with industry leaders. https://t.co/wTGmvhqyQu
#AUTOMAplus2024#Automa2024
Learn how #digitaltwins are revolutionizing the #pharma supply chain in our latest PLA Insights episode
https://t.co/Lgua1R7jJK
Our xLab develops innovative solutions to #healthcare challenges. Want to get involved? Link in the description.
#Blockchain#supplychainmanagement
National #PharmacyWeek is here! #AHRQ invites you to explore our Pharmacy Health Literacy Resources designed to boost communication and ensure patients understand their medications. https://t.co/6wONmSgz1V
Are clinical trials leaving underserved communities behind? Research excluding diverse populations lead to biased treatment development & health disparities.
To learn more about how #Decentralization is revolutionizing #clinicaltrials, read here: https://t.co/Vio7ilD0or
Ever wonder why it takes so long for groundbreaking therapies to hit the market? ⏳
Patient recruitment is a huge bottleneck. Without the right tools, it can be a disorganized and inefficient process filled with compliance risks. 🔄⚠️
At Modern Trials, we’re focusing on solving these challenges to help bring therapies to patients faster.
🛠️ Big changes are on the horizon in 2025 – stay tuned! 🌟
#ClinicalResearch #MedicalAdvancements #InnovationInHealthcare
New Author Podcast Research Update
Creating a Health Data Marketplace for the Digital Health Era | Blockchain in Healthcare Today https://t.co/E39Zcp5FjT
To listen go to https://t.co/And2dNIXQr
Thrilled to announce that Kurt Nielsen, President of Partisia Blockchain, has been named one of Bitcoin Insider's Top 120 Digital Asset Influencers in Europe! 🏆 His commitment to privacy-preserving blockchain solutions is shaping the future of data security 🔒 Read the full article ➪ https://t.co/8T2IMYzoqu
@BitcoinInsider5 #PartisiaBlockchain #DigitalAssets #DataPrivacy
Exciting news! Stefan Schwarzfischer, Dr.-Eng., will present "AI and Blockchain for Pharma Supply Chains" @cscmp Roundtable in Zurich.
He’ll discuss one of PLA's pioneering initiatives, our Supply Chain Traceability project.
#supplychaindigitalization#HealthcareInnovation
In today's health landscape, with an increased demand for personalized treatments, putting patients at the center is more important than ever. However, a patient-centered approach does not only benefit the patients themselves...
https://t.co/6UWb6eHmwf
#futureofhealthcare
It is essential to improve #supplychain management & arm healthcare providers & public with info & tools to help protect us all. We must work together to reduce the prevalence of #falsifiedmedicines, save patients' lives and combat the growing threat of antimicrobial resistance.
The WHO estimated in 2017 that 10% of medical products circulating in low- and middle-income countries are substandard or falsified. While concerning, this figure may no longer be reflective of the current situation...
👇
The study found that 𝐌𝐎𝐑𝐄 than 𝐎𝐍𝐄-𝐅𝐈𝐅𝐓𝐇 of the medicines tested failed quality control standards. Such medicines can lead to severe health complications for those taking them, and lead to the development of antibiotic resistance for the globe.
Join us in welcoming Dr. Stefan Schwarzfischer, he will certainly bring a wealth of experience to PharmaLedger, guiding us through our next chapter of maturity.
Read the full press release for more on Dr. Schwarzfischer and his vision for the future.
https://t.co/qaR01WgbsJ
Today we announce a leadership transition with Dr. Stefan Schwarzfischer as our new Executive Director. He'll succeed Daniel Fritz, who helped create and expand our Digital Trust Ecosystem, & launch our first graduated solution, ePI by PharmaLedger™
https://t.co/qaR01WgbsJ
👇